| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507822 | Acta Pharmaceutica Sinica B | 2018 | 13 Pages |
Abstract
Mesoporous silica nanoparticles (MSNs) with unique properties have attracted increasing interest for biomedical applications. Particularly, MSNs have shown great potential to deliver poorly soluble drugs, anticancer agents, and therapeutic genes.233
Keywords
PEIPDEAEMAFDAPDMAEMAAPTMSPEG400MRP1P-gpPLLTMBLHRHPTXMSNsBcl-2RGDNIRCPTCTABCMCMDRpDNA3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide3-aminopropyltriethoxysilaneMTTP-glycoproteinarginine-glycine-aspartateAcridine orangeCetyltrimethyl ammonium bromideGene deliveryTATEPRPoorly soluble drugGastrointestinalBCsFood and Drug AdministrationCancer therapyBiopharmaceutical classification systemcritical micelle concentrationB-cell lymphoma-2Multi-drug resistanceMultidrug resistanceAPTESMesoporous silica nanoparticlesNear-infraredEnhanced permeability and retentionPAMAMPaclitaxelmultidrug resistance protein 1Plasmid DNAPolyamidoaminePolyethylene glycol 400polyethyleneiminePoly-l-lysinecamptothecin
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Yixian Zhou, Guilan Quan, Qiaoli Wu, Xiaoxu Zhang, Boyi Niu, Biyuan Wu, Ying Huang, Xin Pan, Chuanbin Wu,